Browsing Tag
ASCENIV
1 post
ADMA Biologics stock has jumped 13% in a week, so why does the August 10 lawsuit deadline still matter?
ADMA Biologics is approaching an August 10 lead-plaintiff deadline in a securities class action at a moment when stronger ASCENIV sales, higher margins and improved cash generation are complicating the investment narrative.